Roche
Roche has grown into one of the world’s largest biotech companies, as well as a leading provider of in vitro diagnostics and a global supplier of transformative, innovative solutions across major disease areas. They are a global pioneer in pharmaceuticals and diagnostics, focused on advancing science to improve people’s lives. The combined strengths of pharmaceuticals and diagnostics under one roof have made Roche the leader in personalised healthcare – a strategy that aims to fit the right treatment to each patient in the best way possible.
Latest Roche Content
Product News
Qnovia, Inc. Raises $17 Million in Series A Funding To Advance Its Inhalable Therapeutics Pipeline
Qnovia, Inc., a pharma company developing inhaled therapeutics with an initial focus on nicotine replacement therapy and cardiopulmonary diseases, has announced it has raised $17 million in Series A funding.
Industry Insight
“Rewriting the Textbook” for Precision Medicine
Technology Networks recently had the pleasure of speaking with Mark Fidock, vice president for Diagnostic Development, Precision Medicine at AstraZeneca, to find out how the company is “rising to the challenge” of delivering precision medicines for chronic diseases.
Product News
PhoreMost Enters Multi-Project Drug Target Discovery Collaboration With Roche
PhoreMost Ltd. today announced it has entered into a multi-project target discovery collaboration with Roche.
Product News
Medix Biochemica Appoints Dr. Michele Pedrocchi to Its Board of Directors
Medix Biochemica has announced the appointment of Dr. Michele Pedrocchi to their Board of Directors.
News
Key to Hepatitis A Replication Discovered
Scientists have discovered how a protein and enzymes interact to allow hepatitis A virus to replicate, and then used a known drug to stop viral replication in an animal model.
News
New Brain-Permeable Drug Targets Melanoma Brain Metastases
Researchers have demonstrated striking preclinical efficacy of a BRAF inhibitor, C1a, that can cross the blood–brain barrier and has potent activity against melanoma metastases in the brain.
News
Blood Test Predicts Response to Immunotherapy
Measuring the total mutations in the DNA of cancer cells from circulating tumor DNA found in the blood can predict how a non-small cell lung cancer patient will respond to immunotherapy.
Article
Teach Me in 10 Industry
Our Teach Me in 10 episodes are either technology, product or service focused. We invite you to explore the further reading and resources provided in the video description if you want to learn more about the content shared in the video – it's as easy as that.
Video
Introducing Primer Extension Target Enrichment for NGS With Brian Godwin
In this episode of Teach Me in 10, Lucy Lawrence is joined by Brian Godwin, director of reagent and assay development at Roche Sequencing to discuss primer extension target enrichment for NGS.
Article
In Vitro Diagnostics Needs Seismic Change To Improve Patient Outcomes and Deliver Economic Benefits
In this opinion piece, Andrew Goutler discusses the current state of in vitro diagnostics and how it is time to seize the potential of emerging techniques and technologies to deliver improvements across this vital area of clinical testing.
Advertisement
